NCT00035841View on ClinicalTrials.gov

Phase 2 Study of TLK286 in Metastatic Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 30, 2002

Primary Completion Date

July 31, 2004

Study Completion Date

July 31, 2004

Conditions
Breast Neoplasms
Interventions
DRUG

TLK286

Trial Locations (3)

44195

Cleveland Clinic Taussig Cancer Center, Cleveland

46202

Indiana University Medical Center, Indianapolis

85724

Arizona Cancer Center, Tucson

Sponsors

Lead Sponsor

Telik
All Listed Sponsors
lead

Telik

INDUSTRY